FDA clears Invivo's critical care monitoring system:
This article was originally published in Clinica
Invivo Research, a subsidiary of Pleasanton, California-based Invivo Corporation, has received FDA 510(k) clearance to market its Centurion 2000 central station patient monitoring system to hospitals in the US. The system uses a combination of both wireless and hardwired applications to monitor patients in the critical care setting. Invivo, which recently gained the go-ahead to CE-mark the product for sale in Europe, has already launched the product in international markets. The system was developed and manufactured by Danica-Biomedical - now part of GE Medical Systems.